Red-fleshed Apple as a Novel Anthocyanin-biofortified Food to Improve Cardiometabolic Risk Factors. (AppleCor)
Red-fleshed Apple as a Novel Anthocyanin-biofortified Food to Improve Cardiometabolic Risk Factors: Innovation in Crop and Application to Health.
Sponsor: Ministerio de Ciencia e Innovación, Spain
This PHASE2 trial investigates High LDL-cholesterol Levels and is currently ongoing. Ministerio de Ciencia e Innovación, Spain leads this study, which shows 4 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE2
Status: Not Yet Recruiting → Unknown Status
-
Feb 2019 — Jan 2021 [monthly]
Not Yet Recruiting PHASE2
First recorded
Jan 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ministerio de Ciencia e Innovación, Spain
- Universitat de Lleida
- University Rovira i Virgili
For direct contact, visit the study record on ClinicalTrials.gov .